Intelligence Feed event · Equity · 2026-09-15

    Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant

    Question

    Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant

    Direct answer

    Health Catalyst, Inc. announced the appointment of Simeon Kohl as CEO and President effective September 14, 2026, marking a leadership transition for the healthcare data analytics provider. In connection with the appointment, the compensation committee approved an inducement award of 2,747,385 restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4), structuring executive alignment over a two-year vesting timeline.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-15
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant”, revision 1, evidence through 2026-09-15. https://marketontology.com/market-events/2026-09-15/health-catalyst-appoints-simeon-kohl-as-ceo-with-2-75m-rsu-inducement-grant-d17c54

    EQUITY
    Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
    Health Catalyst, Inc. announced the appointment of Simeon Kohl as CEO and President effective September 14, 2026, marking a leadership transition for the healthcare data analytics provider. In connection with the appointment, the compensation committee approved an inducement award of 2,747,385 restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4), structuring executive alignment over a two-year vesting timeline.
    HCAT
    Impact
    68
    SEP 15
    SIG
    90%
    HCAT
    Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
    Health Catalyst, Inc. announced the appointment of Simeon Kohl as CEO and President effective September 14, 2026, marking a leadership transition for the healthcare data analytics provider. In connection with the appointment, the compensation committee approved an inducement award of 2,747,385 restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4), structuring executive alignment over a two-year vesting timeline.
    → Executive leadership transition and a 2.75M RSU equity inducement package alter HCAT's corporate governance profile and share dilution schedule.
    Impact
    Health Catalyst, Inc. announced the appointment of Simeon Kohl as CEO and President effective September 14, 2026, marking a leadership transition for the healthcare data analytics provider. In connection with the appointment, the compensation committee approved an inducement award of 2,747,385 restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4), structuring executive alignment over a two-year vesting timeline.
    Affected
    HCAT
    Transmission
    Executive leadership transition and a 2.75M RSU equity inducement package alter HCAT's corporate governance profile and share dilution schedule.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    HCATexecutive leadership transition and equity dilutionWatch1-4wSimeon Kohl appointed CEO with 2.75M RSU inducement award vesting over two years.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month